Medicament for the treatment or improvement of rheumatoid arthritis or systemic lupus erythematosus.
摘要
<p>The pharmaceutical composition of the present invention which comprises an interleukin-2 active substance can produce so marked effects on rheumatoid arthritis or systemic lupus erythematosus that it is of great value for the treatment or improvement of these disease.</p>
